Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Anvi Pharmaceuticals Private Limited, is an unlisted private company incorporated on 01 January, 2016. It is classified as a private limited company and is located in Mumbai City, Maharashtra. It's authorized share capital is INR 10.00 lac and the total paid-up capital is INR 10.00 lac.
Anvi Pharmaceuticals's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2019. It's EBITDA has decreased by 38.68% over the previous year. At the same time, it's book networth has increased by 9.01%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR lacs. Based on March 2019 numbers.
-10.91%
-38.68%
-66.27%
9.01%
-27.19%
-4.21
-1.28
-1.66
-18.47
-17.46
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(3)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO |
| Networth | |||
| Borrowings | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO |
| Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|
| Solvency + | |||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||
| Current Ratio | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO |
| Performance | |||
| Gross Margin | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO |
| Return + | |||
| Return on Equity | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||
| Days Payable | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO |
| Working Capital | |||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO |
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Whole-time Director | Balasaheb Shivaji Kakade
Shareholder
|
03545819 | 9 years |
| Whole-time Director | Kundan Rameshwar Gupta
Shareholder
|
07172602 | 9 years |
| Whole-time Director | Rajashekaraiah Manjunatha
Shareholder
|
07413983 | 9 years |
| Director | Mahima Bhat | 09190190 | 2 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| RXN CHEMICALS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| DUGEN PHARMA PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| MEFSTAR PHARMA PRIVATE LIMITED |
Active
|
1.0 L | 2 | Maharashtra |
| RXN LABORATORIES PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
| SANJUI HEALTHCARE PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 1 | Maharashtra |
| ARCHAIC REMEDIES PRIVATE LIMITED |
Active
|
90.0 L | 1 | Maharashtra |
| LIPRIX PHARMA LLP |
Active
|
2.0 L | 1 | Karnataka |
| CLYBAY PRIVATE LIMITED |
Active
|
50.0 L | 1 | Karnataka |
| VEDAYUR BIOSCIENCE PRIVATE LIMITED |
Active
|
15.0 L | 1 | Karnataka |
| LIONELPI CONSULTING PRIVATE LIMITED |
Active
|
1.0 L | 1 | Karnataka |
| BESILCHEM LLP |
Active
|
1.0 L | 1 | Delhi |
| KADUPA PHARMA LLP |
Active
|
1.0 L | 1 | Karnataka |
The incorporation date of ANVI PHARMACEUTICALS PRIVATE LIMITED is 01 January, 2016
The authorized share capital of ANVI PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 10.0 L.
The paid-up capital of ANVI PHARMACEUTICALS PRIVATE LIMITED is INR ₹ 10.0 L.
The registered address of ANVI PHARMACEUTICALS PRIVATE LIMITED is NH 1 FIRST FLOOR OM SADACHAR CHS RAYANIGRAM, SHIMPOLI ROAD MUMBAI Mumbai City Maharashtra - 400092
The CIN number of ANVI PHARMACEUTICALS PRIVATE LIMITED is U24233MH2016PTC271597.
Expand
Delete
Collapse
See
details
